Unlocking Drug Resistance in Multiple Myeloma: Adipocytes as Modulators of Treatment ResponseMaria Ochiai(American University), Kathleen DeCicco-Skinner(American University)CancersAugust 31, 202310.3390/cancers15174347Cited by 8SaveCiteExport RISWatch citationsRelated PapersInhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer|Oncogenesis|2019|33Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes|PLoS ONE|2022|1Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in Tpl2−/− Mice|Cancers|2025|0